Navigation Links
Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea

arter ending March 31, 2007. Genzyme cautions investors not to place substantial reliance on the forward- looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise these statements.

Genzyme(R) is a registered trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-678-999-4572 outside the United States.


    Media Contact:            Investor Contact:

    Maria Cantor              Sally Curley

    (617) 768-6690            (617) 768-6140


CONTACT: Media, Maria Cantor, +1-617-768-6690; Investors, Sally Curley,+1-617-768-6140, both of Genzyme Corp.

Web site: http://www.genzyme.com//

Company News On-Call: http://www.prnewswire.com/comp/113803.html /

Ticker Symbol: (NASDAQ-NMS:GENZ)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Results of Clinical Trial of Hylastan
2. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company ... from its consumer trial with Allumera™, a breakthrough cosmetic ... The RevitAll study was performed with a standard ... Allumera™ improves skin appearance, when compared to exposure by ...
... Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and ... of women, announced today the U.S. Food and ... Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2
(Date:4/26/2015)... Forbes Living is scheduled to air ... is synonymous with clean beaches, sparkling office buildings, and old ... economic influencers in the city on the Pacific Coast of ... pleased to announce the show will be broadcast on Cox ... PDT. Tune in to find out what the effervescent host ...
(Date:4/25/2015)... Diversified Communications has announced the launch ... Integrative Healthcare Symposium Canada, as it’s titled, will ... Sheraton Parkway Toronto North in Ontario. , The ... most anticipated events of the year and will ... event aims to gather multi-disciplined practitioners from all ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 In the ... twelve and above needed treatment for an illicit ... the Substance Abuse and Mental Health Services Administration’s Survey ... Beyond these alarming numbers are harrowing stories of men ... substance abuse . David H. Kerr , founder ...
(Date:4/25/2015)... The impact of the Trivedi Master Wellness™ ... the public and is likely to cause further, more ... June. From March 21st to March 31st, 2015, ... Prayers." More than 600 people participated in the program, ... have reported intense experiences that they attest have transformed ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 The URO CENTER ... Blaivas has been chosen by the New York Academy of ... to medicine in the field of Urology. , Dr. Ferdinand ... his speciality, Genito-Urinary diseases. He was a man of ... field of urology. Not only did he devote his ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Integrative Healthcare Event launching in Canada 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 2Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 3Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3
... not having many close friends contributes to poorer health ... face even greater health risks, research at the University ... adjust to being alone don,t have the same health ... examine the relationships between health and two different types ...
... 18 Fulfilling President Obama,s pledge to "stand with ... Veterans Affairs Eric K. Shinseki announced today that the ... replacement hospital for its existing facility in Denver. ... of the Army,s former Fitzsimons hospital in Aurora.The new ...
... is Autism Awareness Month and to celebrate, renowned osteopathic ... of Kids, Brain Trust, a nonprofit clinic that aims ... validated specialty. KBT will provide one year of free ... is anticipated to begin in Spring 2009 for pediatric ...
... delaying or forgoing treatment may worsen your conditionPLANO, Texas, ... rising medical costs are forcing people to gamble with ... percent of respondents said they have skipped a doctor,s ... residents say they have trouble paying medical bills(1). Delaying ...
... N.C. An X-ray-guided spinal tap procedure fails more than ... used sparingly, if at all, for those patients, according to ... School of Medicine. , The study also shows that the ... a doubling in risk of bleeding for patients older than ...
... merges Rotary,s grassroots strength with agency,s technical expertise ... U.S. Agency for International Development (USAID) and Rotary ... by bringing clean drinking water and basic sanitation ... was announced today at the World Water Forum ...
Cached Medicine News:Health News:Few friends combined with loneliness linked to poor mental and physical health for elderly 2Health News:Few friends combined with loneliness linked to poor mental and physical health for elderly 3Health News:VA to Build Stand-Alone Replacement Hospital in Denver 2Health News:Kids' Brain Trust: A New Nonprofit Gives Parents Hope of Defeating Autism 2Health News:Suffering From Back and Neck Pain? Investing in Treatment Pays Off in the Long Run 2Health News:Suffering From Back and Neck Pain? Investing in Treatment Pays Off in the Long Run 3Health News:Spinal taps carry higher risks for infants and elderly, study shows 2Health News:Spinal taps carry higher risks for infants and elderly, study shows 3Health News:USAID and Rotary Clubs Join to Provide Clean Water and Improved Sanitation Worldwide 2
... hold rotators and agitators for ... be set at 22C (71F) ... 40C (59F to 104F). Uniformity ... to bottom. Recorder is standard ...
This model of bench top refrigerated incubator has been designed to suit the TPS-32 platelet shaker....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
Medicine Products: